NEWS

MEA Warns: Most Common Eye Diseases Have No Early Symptoms

February is Save Your Vision Month, and Matossian Eye ... | read full article

Smallest FDA-Approved Medical Device Now Available for Patients with Cataracts and Glaucoma Wednesday, January 29, 2014

Eye surgeon Ilya Rozenbaum, MD of Matossian Eye Associates announced that... | read full article

College Student Shadows an Ophthalmologist

Hopewell, NJ - Jessica Lee, a Princeton resident attending Johns Hopkins... | read full article

read more news stories

EVENTS

Thursday, March 13, 2014 02:00 PM to 05:00 PM

Matossian Eye Associates will be providing FREE vision screening to... | read full article

Tuesday, March 25, 2014 06:30 PM to 08:00 PM

Cynthia Matossian, MD will be giving a lecture to King of Prussia area... | read full article

Thursday, March 27, 2014 10:30 AM to 01:30 PM

MEA will be providing free vision screenings at the Annual Employee ... | read full article

read more events stories

Blog

What Ever Happened to Dilation Reversal Drops?

Posted on: Thursday, September 29, 2011
Author: Matossian Eye Associates

Tags: eye exam, dialation, dapiprazole, pupil constriction

Pupillary dilation is a crutial part of your eye exam, and a most valuable step toward protecting your eye health.  But it is also greatly disliked by most patients.  Dilation drops typically take 4-6 hours to wear off, and during that time blurred vision and light sensitivity remain.  Released in 1991, Rev-Eyes (dapiprazole), promised to revolutionize the practice of eye care by providing a means to reverse dilation.  The new drop counteracted dilation by stimulating pupil constriction.  The reality of the situation was that the drop tended to work slow, often taking a few hours to return pupils to their normal state.  The drop also caused unpleasant side effects such as stinging upon instillation and red eyes in the majority of patients.  It was also expensive, costing 4-5x more than the dilation drops.  Rev-Eyes are no longer available in the United States, but hope remains for an alternative.   
 
Rebecca Mueller, O.D.
 

 

 

Blog Home